Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #41 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Akums Drugs and Pharmaceuticals Limited (this stock) | 12,613 | 109.9 | 7.7% | 81.6% | 0.12% | 66 | 21 | 87 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| June 30, 2026 | 1,167 | 139 | 101 | ₹ |
| March 31, 2026 | 1,158 | 121 | 81 | ₹ |
| Dec. 31, 2025 | 1,160 | 100 | 68 | ₹ |
| Sept. 30, 2025 | 1,018 | 66 | 43 | ₹ |
| June 30, 2025 | 1,024 | 96 | 65 | ₹ |
| March 31, 2025 | 1,056 | 75 | 150 | ₹ |
| Dec. 31, 2024 | 1,010 | 91 | 66 | ₹ |
| Sept. 30, 2024 | 1,033 | 92 | 67 | ₹ |
| June 30, 2024 | 1,019 | 87 | 61 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
| Year ended | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) |
|---|---|---|---|
| March 31, 2026 | 4,359 | 382 | 256 |
| March 31, 2025 | 4,118 | 345 | 344 |
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | 1,181 | -930 | 34 | 231 | 951 |
| March 31, 2025 | 465 | -548 | 73 | 272 | 193 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 5,447 | 3,331 | 3,283 | 73 | 0 | 3,560 | 1,095 | 386 | 1,448 | 756 |
| March 31, 2025 | 4,113 | 3,064 | 3,016 | 14 | 0 | 2,275 | 894 | 101 | 1,390 | 681 |
